BeOne Medicines Ltd.
ONC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 14 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $9.93B in total; no superinvestor holds it.
Other share classesBEIGF
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $309.4M in total
- 14
- 13F holdersQ2 2026, +4 vs. previous quarter
- 283
- 13F valueReported value at the end of Q2 2026
- $9.93B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ONC, Q2 2026
No superinvestor reported holding ONC at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by BeOne Medicines Ltd. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 (view filing)4:49 PM ET | Sep 8 | 2 days | Wang XiaodongDirector, Other: Chair, Scientific Advisory Brd | SSaleAmerican Depositary Shares | −38.3K | $349.10 | −$13.4M | −100.0%0 after | 8 lots10b5-1 |
| Sep 3, 2026 (view filing)5:17 PM ET | Sep 1 | 2 days | Ball Titus B.Principal Accounting Officer | SSaleAmerican Depositary Shares | −132 | $355.86 | −$47.0K | −100.0%0 after | |
| Aug 27, 2026 (view filing)5:12 PM ET | Aug 25 | 2 days | Wu XiaobinPresident and COO | SSaleAmerican Depositary Shares | −280 | $380.00 | −$106.4K | −100.0%0 after | 10b5-1 |
| Aug 13, 2026 (view filing)8:54 PM ET | Aug 11 | 2 days | Lee Chan HenrySVP, General Counsel | SSaleAmerican Depositary Shares | −2.67K | $360.00 | −$959.8K | −100.0%0 after | 10b5-1 |
| Aug 12, 2026 (view filing)5:53 PM ET | Aug 10-12 | 2 days | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −240.8K | $359.12 | −$86.5M | −100.0%0 after | 24 lots10b5-1 |
| Aug 5, 2026 (view filing)5:15 PM ET | Aug 3 | 2 days | Rosenberg AaronChief Financial Officer | SSaleAmerican Depositary Shares | −1.16K | $312.72 | −$361.8K | −100.0%0 after | |
| Aug 3, 2026 (view filing)5:18 PM ET | Jul 30 | 4 days | Lee Chan HenrySVP, General Counsel | SSaleAmerican Depositary Shares | −1.04K | $323.69 | −$337.9K | −100.0%0 after | |
| Jul 24, 2026 (view filing)4:51 PM ET | Jul 22 | 2 days | Lee Chan HenrySVP, General Counsel | SSaleAmerican Depositary Shares | −1.67K | $325.00 | −$542.4K | −100.0%0 after | 10b5-1 |
| Jul 22, 2026 (view filing)5:03 PM ET | Jul 20-21 | 2 days | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −109.7K | $315.28 | −$34.6M | −100.0%0 after | 14 lots10b5-1 |
| Jul 17, 2026 (view filing)5:36 PM ET | Jul 17 | Same day | Oyler JohnChief Executive Officer | SSaleAmerican Depositary Shares | −64.6K | $312.00 | −$20.2M | −100.0%0 after | 9 lots10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in BeOne Medicines Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 8,801,567 | $2.51B | 12.57% | +2,5140.0% | Added |
| Primecap Management Co | 5,007,931 | $1.43B | 0.84% | +32,750+0.7% | Added |
| Capital International Investors | 4,210,221 | $1.20B | 0.25% | +51,495+1.2% | Added |
| FMR LLC | 2,478,527 | $706.3M | 0.03% | −1,215,083−32.9% | Reduced |
| Capital World Investors | 2,249,582 | $641.1M | 0.08% | +626,895+38.6% | Added |
| Citadel Advisors LLC | 1,425,517 | $406.2M | 0.23% | +393,219+38.1% | Added |
| Temasek Holdings (Private) Ltd | 845,729 | $241.0M | 0.66% | −16,914−2.0% | Reduced |
| Price T Rowe Associates Inc | 758,752 | $216.2M | 0.02% | +218,983+40.6% | Added |
| BlackRock, Inc. | 694,618 | $197.9M | 0.00% | +37,117+5.6% | Added |
| Millennium Management LLC | 543,323 | $154.8M | 0.10% | +338,477+165.2% | Added |